These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 20094025)

  • 41. Immunogenicity and safety of BERNA-YF compared with two other 17D yellow fever vaccines in a phase 3 clinical trial.
    Pfister M; Kürsteiner O; Hilfiker H; Favre D; Durrer P; Ennaji A; L'Age-Stehr J; Kaufhold A; Herzog C
    Am J Trop Med Hyg; 2005 Mar; 72(3):339-46. PubMed ID: 15772332
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vaccine administration decision making: the case of yellow fever vaccine.
    Lown BA; Chen LH; Wilson ME; Sisson E; Gershman M; Yanni E; Jentes ES; Hochberg NS; Hamer DH; Barnett ED
    Clin Infect Dis; 2012 Sep; 55(6):837-43. PubMed ID: 22670048
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of a viscerotropic yellow fever vaccine variant from a patient in Brazil.
    Engel AR; Vasconcelos PF; McArthur MA; Barrett AD
    Vaccine; 2006 Apr; 24(15):2803-9. PubMed ID: 16464518
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Yellow fever vaccine for patients with HIV infection.
    Barte H; Horvath TH; Rutherford GW
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD010929. PubMed ID: 24453061
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Yellow fever vaccination status and safety in hemodialysis patients.
    Facincani T; Guimarães MN; De Sousa Dos Santos S
    Int J Infect Dis; 2016 Jul; 48():91-5. PubMed ID: 27208638
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Yellow fever: an emerging threat for Kenya and other east African countries.
    Sanders EJ; Tukei PM
    East Afr Med J; 1996 Jan; 73(1):10-2. PubMed ID: 8625854
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Innate immunity phenotypic features point toward simultaneous raise of activation and modulation events following 17DD live attenuated yellow fever first-time vaccination.
    Martins MA; Silva ML; Elói-Santos SM; Ribeiro JG; Peruhype-Magalhães V; Marciano AP; Homma A; Kroon EG; Teixeira-Carvalho A; Martins-Filho OA
    Vaccine; 2008 Feb; 26(9):1173-84. PubMed ID: 18243433
    [TBL] [Abstract][Full Text] [Related]  

  • 48. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?
    Lopez AS; Guris D; Zimmerman L; Gladden L; Moore T; Haselow DT; Loparev VN; Schmid DS; Jumaan AO; Snow SL
    Pediatrics; 2006 Jun; 117(6):e1070-7. PubMed ID: 16740809
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risks associated with fresh whole blood and red blood cell transfusions in a combat support hospital.
    Spinella PC; Perkins JG; Grathwohl KW; Repine T; Beekley AC; Sebesta J; Jenkins D; Azarow K; Holcomb JB;
    Crit Care Med; 2007 Nov; 35(11):2576-81. PubMed ID: 17828033
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Eliminating yellow fever epidemics in Africa: Vaccine demand forecast and impact modelling.
    Jean K; Hamlet A; Benzler J; Cibrelus L; Gaythorpe KAM; Sall A; Ferguson NM; Garske T
    PLoS Negl Trop Dis; 2020 May; 14(5):e0008304. PubMed ID: 32379756
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fever, jaundice, and multiple organ system failure associated with 17D-derived yellow fever vaccination, 1996-2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Aug; 50(30):643-5. PubMed ID: 11787575
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place?
    Barrett AD; Teuwen DE
    Curr Opin Immunol; 2009 Jun; 21(3):308-13. PubMed ID: 19520559
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety of yellow fever vaccination in pregnancy: findings from a cohort of active duty US military women.
    Hall C; Khodr ZG; Chang RN; Bukowinski AT; Gumbs GR; Conlin AMS
    J Travel Med; 2020 Sep; 27(6):. PubMed ID: 32830852
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Observational study on immune response to yellow fever and measles vaccines in 9 to 15-month old children. Is it necessary to wait 4 weeks between two live attenuated vaccines?
    Michel R; Berger F; Ravelonarivo J; Dussart P; Dia M; Nacher M; Rogier S; Moua D; Sarr FD; Diop OM; Sall AA; Baril L
    Vaccine; 2015 May; 33(20):2301-6. PubMed ID: 25843268
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events.
    Khromava AY; Eidex RB; Weld LH; Kohl KS; Bradshaw RD; Chen RT; Cetron MS;
    Vaccine; 2005 May; 23(25):3256-63. PubMed ID: 15837230
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fatal yellow fever in a traveler returning from Amazonas, Brazil, 2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Apr; 51(15):324-5. PubMed ID: 11990236
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Yellow fever vaccine: an effective vaccine for travelers.
    Verma R; Khanna P; Chawla S
    Hum Vaccin Immunother; 2014; 10(1):126-8. PubMed ID: 24056028
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immune response during adverse events after 17D-derived yellow fever vaccination in Europe.
    Bae HG; Domingo C; Tenorio A; de Ory F; Muñoz J; Weber P; Teuwen DE; Niedrig M
    J Infect Dis; 2008 Jun; 197(11):1577-84. PubMed ID: 18419548
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antibody response to 17D yellow fever vaccine in Ghanaian infants.
    Osei-Kwasi M; Dunyo SK; Koram KA; Afari EA; Odoom JK; Nkrumah FK
    Bull World Health Organ; 2001; 79(11):1056-9. PubMed ID: 11731813
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adverse events following yellow fever vaccination in immunocompromised persons.
    Lara AN; Miyaji KT; Ibrahim KY; Lopes MH; Sartori AMC
    Rev Inst Med Trop Sao Paulo; 2021; 63():e13. PubMed ID: 33656136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.